SpringWorks Therapeutics Announces Data to be Presented at the 2024 American Society of ...
– Results from pivotal Phase 2b ReNeu trialofmirdametinib in patients with NF1-PN to be presented in an oral presentation –
Stay updated with breaking news from Oral Presentations. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
– Results from pivotal Phase 2b ReNeu trialofmirdametinib in patients with NF1-PN to be presented in an oral presentation –
SUZHOU, China and ROCKVILLE, Md., March 27, 2024 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, today announced its annual results for the full year 2023. During the reporting period, Ascentage Pharma made further strides in revenue generation through its commercialized product, achieved...
FOR IMMEDIATE RELEASE: Compugen Selected for two Oral Presentations at the Keystone Symposium on Cancer Immunotherapy ...
/PRNewswire/ -- Ascentage Pharma (6855.HK), a commercial stage global biopharmaceutical company engaged in developing novel therapies for cancer, chronic...
Regional college and high school students earned top awards for their project entries in Westminster College’s 16th annual Student Symposium on the Environment held Dec. 7.